Nearly 900 residents of Taranto County have died of coronavirus since the trace began in March.
This story will be updated throughout the day on Wednesday, December 2, 2020.
A 20-year-old man from Fort Worth is among the newest people to die from COVID-19, officials said on Wednesday.
Taranto County health officials reported four other deaths, including an 80s Hearst woman and a 40-year-old Fort Worth woman.
Officials said all but one in five had a basic health condition, but did not specify which person had no high-risk factors.
The latest information on Wednesday led to the county̵
The county also announced 1,730 new cases. However, the county saw a slight decline in hospitalizations, as its COVID-19 dashboard said there were currently 881 patients, compared with 896.
Dallas County reports 1,640 new cases
Dallas County health officials added 1,640 confirmed cases of COVID-19 on Wednesday, leading to 129,193 since the start of follow-up in March.
Of these new cases, 233 were from antigen tests and were considered probable.
Judge Clay Jenkins wrote on Twitter that Wednesday’s new figures must be accurate because “all reporting agencies are back online with regular reporting after the Thanksgiving holiday weekend.”
The county also has three new deaths. These include a Lancaster woman in her 40s and a Dallas woman in her 70s who both had high-risk illnesses. A Duncanville woman in her 60s also died without suffering from health problems.
There are now 1,221 confirmed deaths.
Bamlanivimab treatment is available at a Dallas hospital
A Dallas hospital announced on Wednesday that it now offers infusions of bamlanivimab with monoclonal antibodies on a limited basis.
Medical City Healthcare officials said the treatment was available to patients who tested positive for COVID-19 and had other high-risk factors.
In a news release, health officials said high-risk conditions that may qualify for treatment include:
- Chronic kidney disease
- Immunosuppressive disease
- Heart disease
Medical City Healthcare officials said the antibody therapy aims to help anyone 12 years of age or older who has a mild to moderate coronavirus case and is at risk of developing a more severe version of the disease.
The hospital added that among children, some other major health conditions that are eligibility considerations include sickle cell disease, neurodevelopment and asthma.
Before receiving bamlanivimab therapy, patients should receive a recommendation from a doctor at Medical City Healthcare. People who are considered eligible will then receive a dose through IV.
The hospital said bamlanivimab was not approved for people hospitalized for COVID-19, required oxygen therapy due to coronavirus, or other underlying medical conditions.
Denton County has a record number of COVID-19 hospitalizations
On Tuesday, Denton County health officials reported 140 hospitalized with COVID-19. On Monday, the county also reported a record high 143 hospitalizations.
The county released those numbers on Wednesday.
The previous record was 141, which was set on both November 24 and November 25.
There were at least 100 people in the hospital with COVID-19 for 22 consecutive days, a record in the county.
Denton County Health officials report that the percentage of patients with COVID-19 is currently 16.4%. This capacity remains above 15% as of November 21.
Grayony Grayson, Henderson set new daily records
Grayson County had a record 257 confirmed cases of COVID-19 on Tuesday.
The previous recording took place on November 24, when there were 208 new reported cases.
The county currently has an average of 14 days out of 71.43 cases per day. The current record is 79.86, happening from November 11 to 24.
Henderson County had a record 87 confirmed cases of COVID-19 on Tuesday.
The previous recording took place on July 14, when there were 63 new cases registered.
The county currently has a 14-day average of 18.79 cases per day. The current record is 21.64, happening from November 8 to 21.
For a daily review of the latest North Texas news aand beyond, Sign up for the WFAA email newsletter.